# 76329-3352-1 · Sodium Bicarbonate Injection · Amphastar Pharmaceuticals, Inc. — FDA drug shortage duration tracker For 76329-3352-1 · Sodium Bicarbonate Injection · Amphastar Pharmaceuticals, Inc., package ndc is 76329-3352-1; generic name is Sodium Bicarbonate Injection; manufacturer is Amphastar Pharmaceuticals, Inc; status is Current; availability now is Limited Availability, recorded from its source on 2026-09-01; source re-checked 2026-09-08. - **Package NDC:** 76329-3352-1 _(verified: appears in the quote below)_ - **Generic name:** Sodium Bicarbonate Injection _(verified: appears in the quote below)_ - **Manufacturer:** Amphastar Pharmaceuticals, Inc. _(verified: appears in its own passage below)_ - **Status:** Current _(verified: appears in its own passage below)_ - **Availability now:** Limited Availability _(verified: appears in the quote below)_ - **FDA note:** Available on allocation _(verified: appears in the quote below)_ - **Initial posting date:** 03/01/2017 _(verified: appears in the quote below)_ - **Last update date:** 08/18/2026 _(verified: appears in its own passage below)_ - **Days in shortage:** 3471 _(our reading, not quoted from the source)_ - **Reason for shortage:** Demand increase for the drug _(verified: appears in its own passage below)_ - **Dosage form:** Injection _(verified: appears in its own passage below)_ - **Therapeutic category:** Endocrinology/Metabolism _(verified: appears in its own passage below)_ ## What the source says > "initial_posting_date": "03/01/2017", "package_ndc": "76329-3352-1", "generic_name": "Sodium Bicarbonate Injection", "contact_info": "800-423-4136", "availability": "Limited Availability", "related_info": "Available on allocation" ## Where each value comes from This source states these in separate places, so each value is shown with the passage that states it. ### Manufacturer > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Status > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Last update date > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Reason for shortage > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Dosage form > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ### Therapeutic category > "update_date": "08/18/2026", "therapeutic_category": [ "Endocrinology/Metabolism", "Gastroenterology", "Pediatric" ], "dosage_form": "Injection", "presentation": "Sodium Bicarbonate, Injection, 84 mg/1 mL (NDC 76329-3352-1)", "company_name": "Amphastar Pharmaceuticals, Inc.", "shortage_reason": "Demand increase for the drug", "status": "Current" ## Source - https://api.fda.gov/drug/shortages.json?search=company_name%3A%22Amphastar%20Pharmaceuticals,%20Inc.%22+AND+generic_name%3A%22Sodium%20Bicarbonate%20Injection%22+AND+status%3A%22Current%22&limit=1000 Last verified: 2026-09-08. Review by: 2026-09-11. Part of [FDA drug shortage duration tracker](https://referencesource.org/drug-shortage-duration-tracker/).